Mensing Shields Generics Makers In Sprawling Darvocet MDL

Law360, New York (March 5, 2012, 9:40 PM EST) -- A Kentucky federal judge on Monday dismissed claims against some generic-drug manufacturers in the massive MDL over injuries tied to painkillers Darvocet, Darvon and their generic equivalents, saying the U.S. Supreme Court’s recent Mensing ruling shielded them from liability.

In a second ruling Monday, U.S. District Judge Danny C. Reeves also dismissed some claims against brand-name manufacturer Xanodyne Pharmaceuticals Inc., saying the plaintiffs never argued that Xanodyne had manufactured the drugs that sickened them.

In ruling for the generics makers, Judge Reeves cited the Supreme Court’s...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.